Lack of association between plasma lipoprotein(a) concentrations and the presence or absence of coronary atherosclerosis

Acta Cardiologica

Volumn 57, Issue 6, 2002, Pages 409-414

  Auer, Johann ^a   Rammer, Martin ^a   Berent, Robert ^a   Weber, Thomas ^a   Lassnig, Elisabeth ^a   Eber, Bernd ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Coronary angiography; Coronary artery disease; Lipoprotein(a)

Indexed keywords

FIBRINOGEN; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN;

ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SEX DIFFERENCE;

AGE DISTRIBUTION; AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COHORT STUDIES; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; HYPERLIPOPROTEINEMIAS; MALE; MIDDLE AGED; PREVALENCE; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC;

EID: 0036920914     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.57.6.2005464     Document Type: Article

References (30)

1. Wilhelmsen L, Wedel H, Tibblin G. Multivariate analysis of risk factors for coronary heart disease. Circulation 1973; 48: 950-8.
2. Wald NJ, Law M, Watt HC, Wu T, Bailey A, Johnson AM, Craig WY, Ledue TB, Haddow JE. Apolipoproteins and ischaemic heart disease: Implications for screening. Lancet 1994; 343: 75-9.
3. Stamfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins and the risk of myocardial infarction. N Engl J Med 1991; 325: 373-81.
4. Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. J Am Med Assoc 1986; 256: 2540-4.
5. Sandkamp M, Funke H, Schulte H, Köhler E, Assmann G. Lipoprotein(a) is an independent risk factor for myocardial infarction at young age. Clin Chem 1990; 36: 20-3.
6. Utermann G. The mysteries of lipoprotein(a). Science 1989; 246: 904-10.
7. Lackner C, Boerwinkle E, Leffert C, Rahmig T, Hobbs HH. Molecular basis of apolipoprotein(a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J Clin Invest 1991; 87: 2077-86.
8. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 1992; 90: 52-60.
9. Albers JJ, Marcovina SM, Lodge MS. The unique lipoprotein(a): Properties and immunochemical measurement. Clin Chem 1990; 36: 2019-2026.
10. Sandholzer C, Hallman DM, Saha N, Sigurdsson G, Lackner C, Csaszar A, Boerwinkle E, Utermann G. Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups. Hum Genet 1991; 86: 607-14.
11. Moliterno DJ, Jokinen EV, Miserez AR, Lange RA, Willard JE, Boerwinkle E, Hillis LD, Hobbs HH. No association between plasma lipoprotein(a) concentrations and the presence or absence of coronary atherosclerosis in African-Americans. Arterioscler Thromb Vasc Biol 1995; 15: 850-5.
12. Zampoulakis JD, Kyriakousi AA, Poralis KA, Karaminas NT, Palermos ID, Chimonas ET, Cokkinos DV. Lipoprotein(a) is related to the extent of lesions in the coronary vasculature and to unstable coronary syndromes. Clin Cardiol 2000; 23: 895-900.
13. Rhoads GG, Dahlèn GH, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. J Am Med Assoc 1986; 256: 2540-44.
14. Dahlèn GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM Jr. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986; 74: 758-65.
15. Armstrong VW, Cremer P, Eberle E, Manke A, Schulze F, Wieland H, Kreuzer H, Seidel D. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis: Dependence on serum LDL levels. Atherosclerosis 1986; 62: 249-57.
16. Budde T, Fechtrup C, Bosenberg E, Vielhauer C, Enbergs A, Schulte H, Assmann G, Breithardt G. Plasma Lp(a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis. Arterioscler Thromb 1994; 14: 1730-6.
17. Lipid Research Clinics Program. Lipid and lipoprotein analysis: manual of laboratory operations. Washington, DC: US Dept of Health, Education, and Welfare; 1982. Pub. No. NIH/75-628.
18. Abell LL, Levy BB, Brodie BB, Kendall FE. A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem 1952; 195: 357-66.
19. Menzel HJ, Dieplinger H, Lackner C, Hoppichler F, Lloyd JK, Muller DR, Labeur C, Talmud PJ, Utermann G. A beta-lipoproteinemia with an apoB-100-lipoprotein(a) glycoprotein complex in plasma. J Biol Chem 1990; 265: 981-6.
20. Ridker PM, Hennekens CH, Stampfer MJ. A prospective study of lipoprotein(a) and the risk of myocardial infarction. J Am Med Assoc 1993; 270: 2195-9.
21. Jauhiainen M, Koskinen P, Ehnholm C, Frick MH, Mänttäri M, Manninen V, Huttunen JK. Lipoprotein(a) and coronary heart disease risk: A nested case-control study of the Helsinki Heart Study participants. Atherosclerosis 1991; 89: 59-67.
22. Alfthan G, Pekkanen J, Jauhiainen M, Karvonen M, Tuomilehto J, Salonen JT, Ehnholm C. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 1994; 106: 9-19.
23. Ramachandran A, Sathyamurthy I, Snehalatha C, Satyavani K, Sivasankari S, Misra J, Girinath MR, Viswanathan V. Risk variables for coronary artery disease in Asian Indians. Am J Cardiol 2001; 87: 267-71.
24. Dangas G, Ambrose JA, D'Agate DJ, Shao JH, Chockalingham S, Levine D, Smith DA. Correlation of serum lipoprotein(a) with the angiographic and clinical presentation of coronary artery disease. Am J Cardiol 1999; 83: 583-5.
25. Gupta R, Vasisht S, Bahl VK, Wasir HS. Correlation of lipoprotein(a) to angiographically defined coronary artery disease in Indians. Int J Cardiol 1996; 57: 265-70.
26. Paultre F, Pearson TA, Weil HF, Tuck CH, Myerson M, Rubin J, Francis CK, Marx HF, Philbin EF, Reed RG, Berglund L. High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men. Arterioscler Thromb Vasc Biol 2000; 20: 2619-24.
27. Rader DJ, Hoeg JM, Brewer HB. Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease. Ann Intern Med 1994; 120: 1012-25.
28. Keil JE, Sutherland SE, Knapp RG, Lackland DT, Gazes PC, Tyroler HA. Mortality rates and risk factors from coronary disease in black as compared with white men and women. N Engl J Med 1993; 329: 73-8.
29. Fontana P, Mooser V, Bovet P, Shamlaye C, Burnand B, Lenain V, Marcovina SM, Riesen W, Darioli R. Dose-dependent inverse relationship between alcohol consumption and serum Lp(a) levels in black African males. Arterioscler Thromb Vasc Biol 1999; 19: 1075-82.
30. Jenner JL, Ordovas JM, Lamon-Fava S, Schaefer MM, Wilson PWF, Castelli WP, Shaefer EJ. Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels: The Framingham Offspring Study. Circulation 1993; 87: 1135-41.